P - Contraindicated in pregnancy
L - Contraindicated in lactation
Lornoxicam (chlortenoxicam) is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and parenteral formulations.
Lornoxicam is an NSAID that is used in musculoskeletal, joint disorders and other painful conditions including postoperative pain. Lornoxicam is a potent inhibitor of both COX-1 and COX-2 enzymes.
Absorption
Extensively absorbed from the GI tract. Peak plasma concentration within 1-2 hours (oral) or 25 min (IM).
Distribution
99% bound to plasma proteins.
Metabolism
Metabolised to its inactive metabolite.
Excretion
Excreted in the faeces (as metabolites) and urine (as unchanged drug). Mean elimination half life of 3-4 hours.
Information Not Available
Abdominal pain, diarrhoea, dizziness, dyspepsia, nausea, vomiting; headache; haematologic disorders; CNS effects; visual disturbance; tinnitus; nephrotoxicity; fluid retention; photosensitivity; alveolitis; pancreatitis; Stevens-Johnson syndrome; toxic epidermal necrolysis; colitis induction/exacerbation; stomatitis; hypertension, palpitation; insomnia, somnolence.
Information Not Available
Active infections; asthma; allergic disorders; haemorrhagic disorders; hypertension; impaired renal, hepatic, cardiac function.
Increased lornoxicam blood conc when given concomitantly with cimetidine.Enhanced effects of anticoagulants, sulfonylureas, methotrexate, ciclosporin, digoxin. Decreased effects of diuretics, ACE inhibitors.
Potentially Fatal: Increased risk of lithium toxicity.
Information Not Available
Oral
Pain relief
Adult: 8-16 mg daily. Max: 24 mg daily.
Oral
Osteoarthritis
Adult: 12 mg daily in 2-3 divided doses, up to 16 mg daily if needed.
Oral
Rheumatoid arthritis
Adult: 12 mg daily in 2-3 divided doses, up to 16 mg daily if needed.
Parenteral
Pain relief
Adult: 8 mg once or twice daily by IM/IV inj. Max: 24 mg daily.
Information Not Available
Contraindicated in pregnancy
Contraindicated in lactation
Information Not Available
Information Not Available
Patients with peptic ulceration; severe renal impairment; pregnancy and lactation.
Information Not Available
Information Not Available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.